Wellington Management Group’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200,336
| Closed | -$555K | – | 1970 |
|
|
2024
Q4 | $555K | Sell |
200,336
-60,383
| -23% | -$167K | ﹤0.01% | 1798 |
|
|
2024
Q3 | $1.36M | Buy |
260,719
+27,739
| +12% | +$145K | ﹤0.01% | 1644 |
|
|
2024
Q2 | $1.04M | Sell |
232,980
-11,220
| -5% | -$50K | ﹤0.01% | 1654 |
|
|
2024
Q1 | $1.87M | Buy |
+244,200
| New | +$1.87M | ﹤0.01% | 1534 |
|
|
2021
Q4 | – | Sell |
-364,600
| Closed | -$4.23M | – | 2234 |
|
|
2021
Q3 | $4.23M | Sell |
364,600
-364,954
| -50% | -$4.23M | ﹤0.01% | 1543 |
|
|
2021
Q2 | $12.4M | Buy |
729,554
+261,937
| +56% | +$4.46M | ﹤0.01% | 1212 |
|
|
2021
Q1 | $9.26M | Buy |
467,617
+28,914
| +7% | +$573K | ﹤0.01% | 1260 |
|
|
2020
Q4 | $9.06M | Buy |
438,703
+134,012
| +44% | +$2.77M | ﹤0.01% | 1211 |
|
|
2020
Q3 | $8.01M | Buy |
+304,691
| New | +$8.01M | ﹤0.01% | 1160 |
|